Treatment of Fabry disease with different dosing regimens of agalsidase: Effects on antibody formation and GL-3

Autor: Vedder, Anouk C., Breunig, Frank, Donker-Koopman, Wilma E., Mills, Kevin, Young, Elisabeth, Winchester, Bryan, Ten Berge, Ineke J.M., Groener, Johanna E.M., Aerts, Johannes M.F.G., Wanner, Christoph, Hollak, Carla E.M.
Zdroj: In Molecular Genetics and Metabolism July 2008 94(3):319-325
Databáze: ScienceDirect
Externí odkaz: